Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemical Optimization of Cerebral Embolectomy
2018-002195-40Phase 2Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Improved angiographic reperfusion at 10 minutes. Started Jul 2018; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2018-002195-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002195-40.